Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Peering Into Upstart Holdings Inc. - Common stock's Recent Short Interest

Upstart Holdings Inc. - Common stock's (NASDAQ:UPST) short percent of float has risen 11.0% since its last report. The company recently reported that it has 10.23 million shares sold short, which is 15.54% of all regular shares that are available for trading.

Benzinga

Expert Ratings For Ionis Pharmaceuticals

Within the last quarter, Ionis Pharmaceuticals (NASDAQ:IONS) has observed the following analyst ratings:

Benzinga

Expert Ratings For Amylyx Pharmaceuticals

Within the last quarter, Amylyx Pharmaceuticals (NASDAQ:AMLX) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What 7 Analyst Ratings Have To Say About Poshmark

Poshmark (NASDAQ:POSH) has observed the following analyst ratings within the last quarter:

Benzinga

4 Penny Stocks Insiders Are Buying: Heritage Global, Palisade Bio And More

US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga

Read news from The Economist, FT, and more,
with one subscription

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Benzinga

10 Industrials Stocks Moving In Friday's Pre-Market Session

Benzinga

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Yatra Online: Q3 Earnings Insights

Yatra Online (NASDAQ:YTRA) reported its Q3 earnings results on Friday, April 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Enveric Biosciences Reports Full-Year 2021 Financial Results

Enveric Biosciences Inc. (NASDAQ:ENVB) reported its financial results for the full year ended December 31, 2021. 2021 Financial Results Comprehensive net loss for the year was $48.8 million, including $36.3 million in net non-cash expenses, with a basic and diluted loss per share of $2.07, as compared to a comprehensive…

Benzinga

High Tide Buys Boreal Cannabis Co, Blessed CBD Makes UK List Of Marijuana Products Permitted To Sell

High Tide Inc. (NASDAQ:HITI) (TSXV:HITI) (FSE:2LYA) is expanding its brick-and-mortar retail cannabis operations, by entering into a definitive agreement through which High Tide will acquire 100% of the equity interest of 2080791 Alberta Ltd. operating as Boreal Cannabis Company that operates two retail cannabis stores in Alberta for CAD$2.2 million, plus the wholesale…

Benzinga

Why Alibaba, Nio And Pinduoduo Shares Are Rising Today

Shares of several Chinese stocks, including Alibaba Group Holding Ltd (NYSE: BABA), Nio Inc (NYSE: NIO) and Pinduoduo Inc (NASDAQ:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Could Robinhood Shares Continue To Fall?

Shares of Robinhood Markets Inc (NASDAQ: HOOD) tanked 7.21% to close Thursday’s trading at $13.51.

Benzinga

Jim Cramer Gives His Opinion On AT&T, Kosmos Energy And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Gevo, Inc. (NASDAQ: GEVO) should be "working better here, but it’s losing too much money."

Benzinga

CNBC's Final Trades: Carlyle Group, Oracle, Kinder Morgan And This Defensive Play

On CNBC’s “Halftime Report Final Trades,” Josh Brown of Ritholtz Wealth Management said he was long on Carlyle Group Inc (NASDAQ: CG).

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Friday, April 1

Reuters IEA Holds Emergency Meeting To Tackle Soaring Oil Prices

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Rosenblatt Analyst Explains How AMD Stock Weakness Is Buying Opportunity

Competitor downgrade on 2023 cyclical issues, potential consumer weakness in PCs and mobile, and a possible price war with Intel Corp (NASDAQ:INTC) drove Advanced Micro Devices Inc (NASDAQ:AMD) shares' weakness, Rosenblatt analyst Hans Mosesmann said. Barclays recently downgraded the rating on AMD, citing looming cyclical risks in 2023 across several end markets. However, Mosesmann contends that AMD is…

Benzinga

10 Biggest Price Target Changes For Friday

Wells Fargo lowered the price target on General Motors Company (NYSE: GM) from $83 to $72. GM shares rose 0.8% to $44.10 in pre-market trading.

Benzinga

S&P 500 Sector Re-shuffling Likely To End Tech Dominance

S&P 500 will reclassify the sectors of some significant shares in 2023. Payment processing companies currently classified as tech firms would join the financial industry. Other tech names providing outsourcing or human resources support would come under industrial stocks. The dominance of tech stocks in the S&P 500 would likely shrink following…

Benzinga

Cathie Wood-Backed Xpeng Beats Rivals Nio, Li Auto In March Deliveries, Records 148% Sequential Surge

Xpeng Inc (NYSE: XPEV) on Friday reported higher monthly delivery numbers than those of the close local rivals Nio Inc (NYSE: NIO) and Li Auto Inc (NASDAQ: LI) as production bounced

Benzinga

ARCA biopharma's Tissue Factor Inhibitor Disappoints In Mid-Stage COVID-19 Study

ARCA biopharma Inc (NASDAQ: ABIO) announced results from the ASPEN-COVID-19 Phase 2 trial evaluating rNAPc2, a specific inhibitor of tissue factor, as a potential treatment for patients hospitalized with COVID-19.

Benzinga

21 Stocks Moving in Friday's Pre-Market Session

Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results.

Benzinga

BTIG Remains Bullish On CoreCard Despite Apple's Move To Bring Financial Service Offerings In-House

The news of Apple Inc (NASDAQ:AAPL) developing payment-processing technology to bring some of its financial-services offerings in-house triggered a meltdown in CoreCard Corp (NYSE:CCRD) share prices. However, BTIG analyst Mark Palmer views the pressure on CoreCard shares as vivid. He sees it as unlikely that Apple's move to bring more of its payment processing in-house would…

1 … 789 790 791 792

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.